Copyright
©The Author(s) 2021.
World J Stem Cells. Jan 26, 2021; 13(1): 1-29
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.1
Published online Jan 26, 2021. doi: 10.4252/wjsc.v13.i1.1
Species | Embryonic stage | Culture medium and condition | Expression of pluripotency markers | Long-term culture (passage) | Karyotype | In vitro differentiation to EBs | In vivo differentiation to teratoma | Germ line transmission | Ref. |
Cattle | CDX2-KD blastocysts | KO-DMEM, 2 mM glutamine, 1% MEM-NEAAs, 20 ng/mL hrFGF, 20 ng/mL hrLIF, 0.1 mM β–mercaptoethanol, 15% FBS + MEF under 37℃, 5% CO2 | Yes | 37 | Normal | Yes | Yes | No | [272] |
Blastocysts | CTFR medium contains low fatty acid BSA, 20 ng/mL hFGF2, 2.5 μM IWR1 + MEFs under 37℃, 5% CO2 | Yes | > 70 | Normal | No | Yes | No | [145] | |
Buffalo | Blastocysts | KO-DMEM, 15% KSR, 2 mM L-glutamine, 50 μg/mL gentamicin sulfate, 1% MEM-NEAAs, 0.1 mM β-mercaptoethanol, 1000 IU/mL mLIF, 5 ng/mL FGF2 + BFF under 37℃, 5% CO2 | Yes | 135 | Normal | Yes | No | No | [20] |
Blastocysts | DMEM, 20% FBS, 2 mM L-glutamine, 0.1 mM β-mercaptoethanol, 2% NEAA, 1% ITS, 50 μg/mL gentamycin sulfate, 30 ng/mL LIF, 40 ng/mL bFGF + BFF under 38.5℃, 5% CO2 | Yes | 15 | Normal | No | Yes | No | [273] | |
Ovine | Blastocysts | DMEM high glucose, 2 mM L-glutamine, 1 mM Na-Pyruvate, 0.1 mM β-mercaptoethanol, 0.1 mM NEAAs, 10 ng/mL LIF, 20 mg/mL insulin, 1000 IU/mL penicillin, 10 mg/mL streptomycin + STO under 38.5℃, 5% CO2 | Yes | No | Normal | Yes | No | No | [274] |
Blastocysts | DMEM/F12 supplemented with N2, B27, GSK3 inhibitor (CHIR99021), rhbFGF + OEF or MEF under 38.5℃, 5% CO2 | Yes | 30 | No | Yes | Yes | No | [275] | |
Caprine | Blastocysts | DMEM, 20% FCS, 1000 IU/mL mLIF, 1% NEAAs 0.1 mM β-mercaptoethanol, 2 mM l-glutamine + GFF under 38.5℃, 5% CO2 | Yes | 15 | Normal | Yes | No | No | [17] |
Blastocysts | DMEM, 0.1 mM 2-mercaptoethanol, 0.1 mM MEM-NEAAs, 2 mM L-glutamine, 10% FBS, 1000 U/mL hLIF + GFF under 37℃, 5% CO2 | Yes | 120 | Normal | Yes | Yes | No | [16] | |
Porcine | Blastocysts | 1:1 ratio of 1. α-MEM medium supplemented with 10% KSR, 0.05 mM β-mercaptoethanol, 1% NEAAs, 1% antibiotic-antimycotic, 4 ng/mL EGF, 10 μL/mL 100 × ITS, 1000 U/mL mLIF, 2 ng/mL bFGF and, 2. DMEM/F-10-based medium supplemented with 15% heat-inactivated FBS, 0.2 mM β-mercaptoethanol, 1% NEAA, 1% antibiotic–antimycotic and 2 ng/mL bFGF + MEFs under 37℃, 5% CO2 | Yes | 19 | Normal | Yes | No | No | [276] |
Blastocysts | α-MEM, 20% KSR, 20 ng/mL bFGF, 20 ng/mL EGF, 10 ng/mL Activin-a, 1% ITS, 1 mM MEM-NEAAs, 55 μM β2-mercaptoethanol + STO at 38.5℃, 5% CO2 | Yes | 21 | Normal | Yes | Yes | No | [277] | |
Blastocysts | DMEM, 20% KSR and N2B27 medium, 1% NEAAs, 2 mM L-glutamine, 1% PS, 0.1 mM b-mercaptoethanol, 3 mM CHIR99021, 1 mM PD0325901, 2 mM SB, and 50 ng/mL vitamin C + MEFs under 38.5℃, 5% CO2 | Yes | 139 | Normal | Yes | Yes | No | [278] | |
Equine | Blastocysts | DMEM/F12, 15% FCS, 1000 U/mL hLIF, 15% FBS + MEF under 38.5℃, 5% CO2 | Yes | 28 | Normal | Yes | No | No | [279] |
Blastocysts | KO-DMEM, 15% FBS, 0.1 mM NEAAs, 2 mM L-glutamine, 1% ITS, 100 μg/mL streptomycin, 100 IU/mL penicillin, 0.1 mM β-mercaptoethanol, hLIF, hbFGF + MEF under 38.5℃, 5% CO2 | Yes | 15 | No | No | No | No | [280] | |
Canine | Blastocysts | KO-DMEM/Ham’s F12, 15% KSR, 1 × GlutaMAX, 1 × NEAAs, R3IGF1, 0.1 mM 2-mercaptoethanol, 10 ng/mL hrLIF, 4 ng/mL rhFGF2, 0.5 μM, MEK inhibitor PD0325901, 3 μM GSK3β inhibitor CHIR99021 + MEFs under 37℃, 5% CO2 | Yes | -- | Normal | Yes | Yes | No | [281] |
Blastocysts | KO-DMEM or DMEM/-12, 0.1 mM β-mercaptoethanol, 5 μM thymidine, 15 μM cytidine, 15 μM guanosine, 15 μM adenosine and 15 μM uridine nucleosides, 0.2 mM GlutaMax, 0.1 mM NEAAs, penicillin (100 IU/mL), streptomycin (50 μg/mL), 10 ng/mL hLIF, 4 ng/mL hbFGF, 15% FBS or KSR + MEFs under 37.5℃, 5% CO2 | Yes | 30 | Normal | Yes | Yes | No | [99] |
Species | Cell type | Culture medium and condition | Expression of pluripotency markers | Long-term culture (passage) | Karyotype | In vitro differentiation to EBs | In vivo differentiation to teratomas | Germline transmission | Ref. |
Cattle | Fetal fibroblasts | DMEM/F-12, 20% KSR, 1 mM l-glutamine, 0.1 mM NEAAs, 0.1 mM mercaptoethanol, 100 U/mL penicillin, 100 μg/mL streptomycin, 8 ng/mL bFGF, 1000 U/mL hLIF on MEF at 37℃ and 5% CO2 | Yes | 40 | Normal | Yes | Yes | No | [58] |
Fetal fibroblasts | KO-DMEM, 15% FBS, 2 mM L-glutamine, 1% NEAAs, 0.1 mM β-mercaptoethanol, 106 U/mL hLIF, 10 ng/mL bFGF on STO at 37℃ and 5% CO2 | Yes | 50 | Normal | Yes | Yes | No | [130] | |
Buffalo | Fetal fibroblasts | DMEM high glucose, 20% ESC-FBS, 2 mM l-glutamine, 1% NEAAs, 0.1 mM β-mercaptoethanol, 10 ng/mL bFGF, 10 ng/mL LIF on MEF at 37℃ and 5% CO2 | Yes | 10 | Normal | Yes | Yes | No | [65] |
Fetal fibroblasts | DMEM/F-12, 20% KSR, 0.1 mM NEAAs, 1 mM L-glutamine, 0.1 mM mercaptoethanol, 100 U/mL penicillin, 100 μg/mL streptomycin, 10 ng/mL bFGF, 1000 U/mL hLIF on gelatine at 37℃ and 5% CO2 | Yes | 15 | Normal | Yes | No | No | [66] | |
Ovine | Embryonic fibroblasts | DMEM, 20% FBS, 1% ITS, 0.1 mM 2-β mercaptoethanol, 1 mM NEAAs, 2 mM glutamine, 4 ng/mL bFGF, 1000 U/mL mLIF on MEFs at 37℃ and 5% CO2 | Yes | 17 | Normal | Yes | Yes | Yes (formation of ICM in tetraploid) | [50] |
Embryonic fibroblasts | KO-DMEM, KSR, 0.1 mM NEAAs, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 8 ng/mL hFGF2, 1000 U/mL mLIF on SNL at 37℃ and 5% CO2 | Yes | 23 | Normal | Yes | Yes | Yes (live-born chimeric lambs) | [67] | |
Caprine | Fetal fibroblasts | DMEM/F12, 20% KSR, 1 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 1% NEAAs, 2% sodium bicarbonate solution, 1000 IU/mL 2i/LIF, 4 ng/mL bFGF on STO at 37℃ and 5% CO2 | Yes | 30 | Normal | Yes | Yes | No | [282] |
Embryonic fibroblasts | KO-DMEM, 20% KSR, 1% NEAA, 1% L-glutamine, 0.1 mM EAA, 1% penicillin /streptomycin, 10 ng/mL FGF2 on GEF at 37℃ and 5% CO2 | Yes | 22 | Normal | Yes | No | No | [283] | |
Porcine | Embryonic fibroblasts and microvascular pericyte cells | LCDMV medium contains 50% neurobasal medium, 50% DMEM/F12, 1 × N2, 0.5 × B27, 5% KSR, 10 ng/mL LIF, 1 μM CHIR99021, 2 μM (S)-(+)-dimethindene maleate, 2 μM minocycline hydrochloride, 40 μg/mL vitamin C on MEF at 37℃ and 5% CO2 | Yes | 28 | Normal | Yes | Yes | Yes (chimeric formation in post-implantation pig conceptuses) | [284] |
Sertoli cells | DMEM/F12, 10% KSR, 10% FBS, 1 mM l-glutamine, 1 mM antibiotic, 1% NEAAs, 0.1 mM β-mercaptoethanol, 10 ng/mL bFGF, 10 ng/mL hLIF on MEF at 37℃ and 5% CO2 | Yes | 50 | Normal | Yes | Yes | No | [285] | |
Equine | Fetal fibroblasts | DMEM/F12, 20% KSR, 10 ng/mL bFGF, 1% penicillin/streptomycin, 10 ng/mL hLIF on MEF at 37℃ and 5% CO2 | Yes | 25 | -- | Yes | No | No | [286] |
Fetal fibroblasts | DMEM, 20% FBS or KO-DMEM, 20% KSR, 2 mM l-glutamine, 0.1 mM β-mercaptoethanol, 0.1 mM MEM- NEAAs, 1% penicillin–streptomycin, 8 ng/mL hbFGF, 1000 U/mL hLIF on SNL at 37℃ and 5% CO2 | Yes | 30 | Normal | Yes | Yes | No | [61] | |
Canine | Embryonic fibroblasts | Serum-free N2B27-based medium, 4 ng/mL hbFGF on MEF at 37℃ and 5% CO2 | Yes | 50 | Normal | Yes | No | No | [287] |
Fetal fibroblasts | KO-DMEM/F12, 20% KSR, 2 mM L-glutamine, 0.1 mM NEAAs, 0.1 mM β-mercaptoethanol, 0.1 mM bFGF on MEF at 37℃ and 5% CO2 | Yes | 15 | Normal | Yes | Yes | No | [288] |
- Citation: Kumar D, Talluri TR, Selokar NL, Hyder I, Kues WA. Perspectives of pluripotent stem cells in livestock. World J Stem Cells 2021; 13(1): 1-29
- URL: https://www.wjgnet.com/1948-0210/full/v13/i1/1.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i1.1